Title
Category
Credits
Event date
Cost
Addressing Patients’ Unmet Needs to Improve Outcomes in Schizophrenia
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in Adults With Comorbid Severe Mental Illness
  • Bipolar Disorder
  • Posttraumatic Stress Disorder
  • Schizophrenia/ Schizoaffective Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
For patients who have PTSD and also have a severe mental illness, can psychotherapies for PTSD still be effective? If so, what component might offer greater efficacy?
Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study
  • Bipolar Disorder
  • Depression
  • Attention-Deficit/Hyperactivity Disorder
  • Autism Spectrum Disorders
  • Child and Adolescent Psychiatry
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Women’s Mental Health
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Is there an association between postpartum depression or psychosis and subsequent disorders in either the mother or the child who is exposed to postpartum maternal illness?
Measurement-Based Diagnosis and Treatment for Tardive Dyskinesia
  • Bipolar Disorder
  • Depression
  • Antipsychotics
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Experts offer a review of the fundamentals of diagnosing and treating tardive dyskinesia.
Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options
  • Antipsychotics
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • Treatment Resistance
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Two experts offer a refresher on predictors and identification of treatment-resistant schizophrenia. Drs Correll and Howes also review therapeutic strategies.
Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking
  • Bipolar Disorder
  • Schizophrenia/ Schizoaffective Disorders
  • Smoking
  • Substance Use Disorders
  • Suicide
  • Veterans and Military Issues
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors.
Part 4: Balancing Safety and Efficacy with Novel Schizophrenia Treatments
  • Schizophrenia/ Schizoaffective Disorders
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Balancing symptoms and side effects is difficult when treating patients with schizophrenia. New approaches to treatment and new therapies in the pipeline offer hope for this difficult-to-treat mental health disorder.
Part 1: A Review of Schizophrenia
  • Schizophrenia/ Schizoaffective Disorders
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Schizophrenia affects 1% of the world’s population largely during a patient’s most productive years. Multiple treatments are available, however many gaps to recovery exist. Learn from experts diagnostic criteria for and defining recovery in schizophrenia.
Part 2: Chasing Cognitive and Negative Symptoms: Unmet Treatment Needs of Patients with Schizophrenia
  • Schizophrenia/ Schizoaffective Disorders
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder’s reward circuitry can help with intervention and patients’ leading more fulfilling lives.
Part 3: Impact of Side Effects on Adherence to Schizophrenia Treatment
  • Schizophrenia/ Schizoaffective Disorders
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
$0.00
Side effects from medication have the greatest impact on adherence for patients with Schizophrenia. They lower quality of life, daily functioning, and satisfaction.

Pages